Specific Anti-Alpha-Gal ImmunoCAPTM Phadia Core Laboratory Testing (ThermoFisher Scientific) for Research Blood Donors
Closed Special Notice Posted
- Solicitation number
- NOI-CC-OLAO-26-008249
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Health, Clinical Center issued a notice of intent on July 23, 2026 to negotiate on a sole-source basis with ThermoFisher Scientific for Phadia Immunology Reference Laboratory testing services; the Government reserves discretion to compete the requirement based on capability statements received by August 2, 2026 at 12:00 PM Eastern time.
The requirement covers anti-alpha-gal and total immunoglobulin E (IgE) testing for research blood donors through ThermoFisher Scientific's Phadia Core Laboratory, which optimizes workflows for allergy and autoimmune diagnostics with calibrated, reliable testing data and improved turnaround time for clinical and research use. The sole-source determination rests on statutory authority under 41 U.S.C. 253(c)(1) as implemented by FAR 6.302-1, citing one responsible source and no other adequate supply or service.
Responsible sources may submit a capability statement by email to valerie.gregorio@nih.gov with subject line NOI-OLAO-CC-26-008249 by the August 2 deadline. All responses received by the closing date will be considered; the Government retains sole discretion to determine whether to compete the requirement.
Notice text
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Phadia
Acquisition Description:
ThermoFisher Scientific Phadia Immunology Reference Laboratory (PiRL), optimizes laboratory workflows for allergy and autoimmune diagnostics including alpha-gal and total immunoglobulin E (IgE), providing calibrated, reliable testing data with efficiency and improved turnaround time for clinical and research use.
The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-26-008249) by 12:00 PM eastern standard time on 08/2/2026 to: valerie.gregorio@nih.gov.
All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Sole Source - NNMC Laboratory Proficiency Testing Services | Indian Health Service | No set-aside | |
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside | |
| iPSC Culture and Differentiation | Office of Logisitics and Acquisition Operations | No set-aside | |
| Combined Synopsis Solicitation- Acquire Maintenanc | Office of Logisitics and Acquisition Operations | No set-aside | |
| NAHLN Diagnostic Testing Services | Marketing and Regulatory Programs Business Services | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity